Investor's Business Daily on MSN
IBD stock of the day Halozyme eyes two buy points; how it's layering up for future growth
Halozyme is Monday's IBD Stock Of The Day. Shares are flirting with a pair of entries after the drug delivery expert issued a ...
Skin and soft tissue infections are more common in children with Crohn’s disease, especially those receiving combination ...
Zacks Investment Research on MSN
Is Inspire Corporate Bond ETF (IBD) a strong ETF right now?
Designed to provide broad exposure to the Investment Grade Corporate Bond ETFs category of the market, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund launched on 07/10/2017.
AstraZeneca made a big commitment to China as CEO Pascal Soriot joined British Prime Minister Keir Starmer on a trip to the ...
LGBTQ+ individuals with inflammatory bowel disease experience multiple gaps and inequities in care when managing their ...
Among patients with IBD in self reported clinical remission, habitual meat intake may affect the risk for flares in those with ulcerative colitis, but not in those with Crohn's disease.
Boehringer Ingelheim has penned a 1.05 billion euro ($1.26 billion) biobucks deal for Simcere’s preclinical inflammatory bowel disease (IBD) bispecific antibody. | Boehringer Ingelheim has penned a 1.
For decades, patients with inflammatory bowel disease have reported a familiar and frustrating pattern: periods of intense ...
University Medical Center has opened a new Center for Inflammatory Bowel Disease. The center provides specialized care for ...
A newly uncovered immune chain reaction in the gut may explain why people with inflammatory bowel disease face a much higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results